MedTrace Logo

Use of Saliva for COVID-19 Diagnosis

NCT04953039 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 109

Last updated 2022-07-26

No results posted yet for this study

Summary

Aim of the study is to evaluate the presence of SARS-CoV2 RNA in the saliva of patients with suspected or confirmed COVID-19 in order to validate the analysis of this type of sample for the diagnosis of SARS-CoV2 infections.

Conditions

  • SARS-CoV2 Infection

Sponsors & Collaborators

  • University of Milano Bicocca

    lead OTHER

Principal Investigators

  • Giorgio Novelli, MD · ASST Monza - Ospedale San Gerardo

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-19
Primary Completion
2021-10-12
Completion
2021-10-12

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04953039 on ClinicalTrials.gov